{
    "id": 4531,
    "fullName": "FGFR4 V550E",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FGFR4 V550E lies within the protein kinase domain of the Fgfr4 protein (PMID: 19809159). V550E has been demonstrated to confer resistance to Fgfr4 inhibitors as a secondary resistance mutation (PMID: 31575540), and confers a gain of function to the Fgfr4 protein as demonstrated by increased autophosphorylation and Stat3 signaling in cultured cells and tumor proliferation in mouse models (PMID: 19809159).",
            "references": [
                {
                    "id": 1834,
                    "pubMedId": 19809159,
                    "title": "Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19809159"
                },
                {
                    "id": 17083,
                    "pubMedId": 31575540,
                    "title": "Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31575540"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2264,
        "geneSymbol": "FGFR4",
        "terms": [
            "FGFR4",
            "CD334",
            "JTK2",
            "TKF"
        ]
    },
    "variant": "V550E",
    "createDate": "04/06/2015",
    "updateDate": "12/19/2019",
    "referenceTranscriptCoordinates": {
        "id": 164672,
        "transcript": "NM_213647",
        "gDna": "chr5:g.177095551T>A",
        "cDna": "c.1649T>A",
        "protein": "p.V550E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19462,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, FGF401 inhibited tumor growth in a transgenic mouse model constitutively expressing FGFR4 V550E (PMID: 31409633).",
            "molecularProfile": {
                "id": 4323,
                "profileName": "FGFR4 V550E"
            },
            "therapy": {
                "id": 2031,
                "therapyName": "FGF401",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17101,
                    "pubMedId": 31409633,
                    "title": "FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31409633"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8393,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, rhabdomyosarcoma cells over expressing FGFR4 V550E demonstrated increased sensitivity to Iclusig (ponatinib), resulting in decreased tumor cell growth in culture and in cell line xenograft models (PMID: 24124571).",
            "molecularProfile": {
                "id": 4323,
                "profileName": "FGFR4 V550E"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3247,
                "name": "rhabdomyosarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 88,
                    "pubMedId": 24124571,
                    "title": "Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24124571"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19590,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing ETV6-FGFR4 and FGFR4 V550E demonstrated resistance to treatment with Fisogatinib (BLU-554) in culture (PMID: 31575540).",
            "molecularProfile": {
                "id": 34267,
                "profileName": "ETV6 - FGFR4 FGFR4 V550E"
            },
            "therapy": {
                "id": 3165,
                "therapyName": "BLU-554",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17083,
                    "pubMedId": 31575540,
                    "title": "Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31575540"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19603,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY2874455 treatment inhibited proliferation of cells co-expressing ETV6-FGFR4 and FGFR4 V550E in culture (PMID: 31575540).",
            "molecularProfile": {
                "id": 34267,
                "profileName": "ETV6 - FGFR4 FGFR4 V550E"
            },
            "therapy": {
                "id": 2032,
                "therapyName": "LY2874455",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 17083,
                    "pubMedId": 31575540,
                    "title": "Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31575540"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 4323,
            "profileName": "FGFR4 V550E",
            "profileTreatmentApproaches": [
                {
                    "id": 9748,
                    "name": "FGFR4 Inhibitor",
                    "profileName": "FGFR4 V550E"
                },
                {
                    "id": 9749,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR4 V550E"
                },
                {
                    "id": 9747,
                    "name": "STAT3 Inhibitor",
                    "profileName": "FGFR4 V550E"
                }
            ]
        },
        {
            "id": 34267,
            "profileName": "ETV6 - FGFR4 FGFR4 V550E",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 164672,
            "transcript": "NM_213647",
            "gDna": "chr5:g.177095551T>A",
            "cDna": "c.1649T>A",
            "protein": "p.V550E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164676,
            "transcript": "NM_022963",
            "gDna": "chr5:g.177095671_177095672delTCinsAG",
            "cDna": "c.1649_1650delTCinsAG",
            "protein": "p.V550E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164674,
            "transcript": "NM_001291980",
            "gDna": "chr5:g.177096088T>A",
            "cDna": "c.1649T>A",
            "protein": "p.V550E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164675,
            "transcript": "XM_005265838",
            "gDna": "chr5:g.177095551T>A",
            "cDna": "c.1649T>A",
            "protein": "p.V550E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164673,
            "transcript": "NM_002011",
            "gDna": "chr5:g.177095551T>A",
            "cDna": "c.1649T>A",
            "protein": "p.V550E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}